HURA - NASDAQ

TuHURA Biosciences, Inc.

HURA·NASDAQ

$2.27

+9.4%

HealthcareBiotechnology

TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$144.24M

EPS-0.6300

P/E Ratio-3.60

Earnings Date08/13/2026

hura

Total Current Liabilities

Last Annual Value

5.92M

3-Year CAGR

27%

5-Year CAGR

16%

10-Year CAGR

25%

Adjust for Inflation

TuHURA Biosciences, Inc. Competitors Analysis of Total Current Liabilities

HURA · NASDAQ

Company	Total Current Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
TuHURA Biosciences, Inc. NASDAQ:HURA	5.92M	18.1%	-3.7%	16.3%
Cognition Therapeutics, Inc. NASDAQ:CGTX	13.92M	11.0%	12.1%	N/A
Seer, Inc. NASDAQ:SEER	15.69M	5.9%	3.2%	N/A
Context Therapeutics Inc. NASDAQ:CNTX	8.02M	24.1%	21.5%	N/A
Ovid Therapeutics Inc. NASDAQ:OVID	8.29M	-10.3%	-10.9%	8.3%
Armata Pharmaceuticals, Inc. AMEX:ARMP	8.95M	-18.4%	13.2%	9.6%
Inovio Pharmaceuticals, Inc. NASDAQ:INO	43.67M	0.9%	-7.9%	-0.0%
Agenus Inc. NASDAQ:AGEN	323.49M	8.1%	15.6%	23.0%
Seres Therapeutics, Inc. NASDAQ:MCRB	19.32M	-41.9%	-25.2%	-4.4%
Acumen Pharmaceuticals, Inc. NASDAQ:ABOS	30.01M	32.3%	42.3%	N/A
VistaGen Therapeutics, Inc. NASDAQ:VTGN	12.61M	40.2%	24.7%	21.5%

TuHURA Biosciences, Inc. Fair Value Envelope

HURA · NASDAQ

Our analysis suggests that HURA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $2.265, this represents a potential HIDDEN relative to our calculated worth for TuHURA Biosciences, Inc..

HIDDEN

Intrinsic Value

Current Price: $2.265

Related Guides

Blog Categories

Continue your HURA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.